Clinical trial of personalized cancer vaccine demonstrates feasibility, safety, immune activation

The first-in-human clinical phase I trial assessing the feasibility and safety of WDVAX, an immunostimulatory ...
The National Law Review

UK MHRA Approval Received for First-In-Human Trial of Rincell-1,

Sheffield, UK, July 1 2025 – Rinri Therapeutics, a world leading company focused on transforming sensorineural hearing loss (SNHL) with regenerative cell therapy, is pleased to announce the approval ...
The Manila Times

ViroMissile Announces First-in-Human Phase I Trial of IDOV-Immune for Advanced Solid Tumors

ViroMissile, Inc., a cancer immunotherapy company pioneering the IDOV™ (Intravenously Deliverable Oncolytic Virus) platform, today announced the initiation of a first-in-human clinical trial ...
The Manila Times

Pan Cancer T Secures EUR 10 Million to Advance First-in-Human Trial of Novel TCR-T Cell Therapy for Triple-Negative Breast Cancer

Pan Cancer T B.V., a biotech company pioneering next-generation T cell therapies for solid tumours, today announced a EUR 10 ...
Morningstar

SK bioscience Files for First-in-Human Trial of Universal Coronavirus Vaccine (Pan-sarbecovirus Vaccine) GBP511 Phase 1/2 study in Australia

SEONGNAM, South Korea, Oct. 15, 2025 /PRNewswire/ -- SK bioscience announced that it has submitted a Phase 1/2 clinical trial application in Australia for GBP511, a universal coronavirus vaccine ...
Morningstar

Myosin Therapeutics Receives FDA Clearance to Initiate First-in-Human Trial of MT-125 in Glioblastoma

JUPITER, Fla., June 9, 2025 /PRNewswire/ -- Myosin Therapeutics, Inc., a clinical-stage biotechnology company developing first-in-class therapies targeting molecular motors, today announced that the U ...
EurekAlert!

From novel therapies to first-in-human trials, City of Hope advances blood cancer care at the American Society of Hematology (ASH) annual conference

Researchers from City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States with its National Medical Center ranked among the nation’s top ...
Nasdaq

ProQR Therapeutics Submits Clinical Trial Application for AX-0810, Initiating First-in-Human Study Targeting Cholestatic Liver Diseases

ProQR Therapeutics announces a Phase 1 trial of AX-0810 to evaluate safety and target engagement in cholestatic liver disease. The initiation of the Phase 1 clinical trial for AX-0810 is contingent ...
EurekAlert!

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

First-in-Human Trial Shows Promising Results for DLL3-Targeted Antibody-Drug Conjugate SHR-4849 in Relapsed Small Cell Lung Cancer (Barcelona, Spain Sunday, September 7, 2025 at 4:45 PM CEST / UTC +2) ...

CYTOMED THERAPEUTICS LIMITED: CytoMed Therapeutics Announces Novel First-In-Human Clinical Trial Collaborations with Renowned and Prestigious Hospital Partner to Advance Its ...

CytoMed Therapeutics Limited (NASDAQ: GDTC) ("CytoMed" or the "Company"), a Singapore-based clinical stage biopharmaceutical company focused on harnessing ...
Premium Times

Oxford begins first human trial of new Lassa Fever vaccine

Thirty-one healthy adults aged 18 to 55 will take part in the trial in Oxford, while a second phase-1 trial is expected to ...
Healio

‘We need this’: Pig-to-human kidney transplants enter clinical trials

Please provide your email address to receive an email when new articles are posted on . Two different gene-edited pig kidneys have been successfully transplanted into living human patients under FDA’s ...